Helvetica Chimica Acta
Pharmaceuticals increasing complexity requires longer synthesis with unique processes for each step, increasing the number of experiments to develop robust sustainable processes. The time to develop these processes is getting shorter, and automation can support the growing need to efficiently perform more experiments. Automation reaction screening focuses more on small- scale high-throughput experimentation (HTE), which may not be applicable for late phase process development. To support these activities and decrease development time, we describe the implementation of a flexible large-scale multi-reactor automation platform for process development.
For details:
Implementation of Large-Scale Multi-Reactor Automation for Process Development
Andreas Kaegi, Markus Spaeti, Jarred Blank
Chemical & Analytical Development, Novartis Pharma, Basel, Switzerland
Helvetica Chimica Acta
https://onlinelibrary.wiley.com/doi/abs/10.1002/hlca.202500120